Enzo Biochem (ENZ) Posts Narrower than Expected Q3 Loss

Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 loss of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $24.77 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Laser Photonics Corporation (LASE) Reports Q1 Loss of $0.11
• PowerFleet, Inc. (AIOT) Misses Q1 EPS by 2c ; Offers Guidance